Forest files fifth patent lawsuit to protect Viibryd

01-04-2015

Forest files fifth patent lawsuit to protect Viibryd

MarcelClemens / Shutterstock.com

Forest Labs, a subsidiary of Actavis, has sued InvaGen for allegedly infringing four patents covering depression drug Viibryd, in what is the fifth related lawsuit.


Forest, InvaGen, Viibryd, patent infringement, US District Court for the District of Delaware

LSIPR